22 Dec Firstkind Secures Regulatory Approval in Argentina
We’re thrilled to announce that Firstkind has received regulatory approval for the geko® device (T-3) in Argentina.
Argentina represents a key market in South America, and this approval marks an important step in bringing innovative medical technology to the region. The geko device offers a non-invasive solution for pre- and post-operative recovery in lower limb trauma and surgery, supporting both oedema management and VTE prevention – areas where effective interventions can dramatically improve patient outcomes and reduce complications.
This milestone underscores the growing opportunity for medtech innovation in Argentina, where advanced therapies can make a meaningful difference in surgical care and non-surgical recovery.
An exciting step forward for Firstkind as we continue expanding access to innovative therapy worldwide!
No Comments